Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Dasatinib × Clear all

Phase

Status

Completed 6 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Acute 2 Leukemia 2 Relapsed Pediatric Solid Tumor 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms 1 Mastocytosis, Systemic 1 Lymphoma, T-Cell, Peripheral 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Gastrointestinal Stromal Tumors 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 18 Drug Therapy 16 pembrolizumab 11 Surveys and Questionnaires 11 Capecitabine 11 Blood Specimen Collection 11 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Biopsy 5 Bevacizumab 5 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡